(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 45.95% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Electrocore's revenue in 2024 is $16,030,000.On average, 2 Wall Street analysts forecast ECOR's revenue for 2024 to be $150,876,055, with the lowest ECOR revenue forecast at $150,065,700, and the highest ECOR revenue forecast at $151,686,410. On average, 2 Wall Street analysts forecast ECOR's revenue for 2025 to be $225,728,826, with the lowest ECOR revenue forecast at $217,895,396, and the highest ECOR revenue forecast at $233,562,255.
In 2026, ECOR is forecast to generate $299,170,980 in revenue, with the lowest revenue forecast at $294,669,009 and the highest revenue forecast at $303,672,951.